PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Kevin Harrington, PhD, FRCR, FRCP - After More Than a Decade: Can We Now Enhance Treatment of Patients With LA SCCHN?
Visit https://www.peervoice.com/FQG860 to view the entire programme with slides. After completing “Kevin Harrington, PhD, FRCR, FRCP - After More Than a Decade: Can We Now Enhance Treatment of Patients With LA SCCHN?”, participants will be able to: Summarize the strengths and limitations of current standards of care for chemoradiation (CRT)-eligible locally advanced squamous cell carcinoma of head and neck (LA SCCHN); Evaluate the role of emerging therapeutic options as part of the treatment paradigm for patients with LA SCCHN who are CRT-eligible based on current clinical evidence; and Identify patient and disease characteristics that may inform eligibility and suitability for novel targeted therapies in patients with LA SCCHN who are CRT-eligible.